awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37270472-6066E086-04F2-4567-B3C9-645ED0EC2142
Q37270472-6066E086-04F2-4567-B3C9-645ED0EC2142
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37270472-6066E086-04F2-4567-B3C9-645ED0EC2142
Evaluation of primary androgen deprivation therapy in prostate cancer patients using the J-CAPRA risk score.
P2860
Q37270472-6066E086-04F2-4567-B3C9-645ED0EC2142
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37270472-6066E086-04F2-4567-B3C9-645ED0EC2142
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7ba15e33cdbaa658d970b9117bd4561af8fcfe6c
P2860
Superior anti-tumor efficacy of bicalutamide 80 mg in combination with a luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist monotherapy as first-line treatment for advanced prostate cancer: interim results of a randomized study